This compound is a pharmaceutical intermediate containing a boronate ester group, designed for use in boronate synthesis. It features a piperidine-substituted pyridine ring structure with moderate lipophilicity and low polarity, characteristic of research intermediates used in medicinal chemistry.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 852228-08-1
1-Methyl-4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine
Research compound
4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]morpholine
Boronic ester research compound
1-(Tetrahydro-2H-pyran-2-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
Pharmaceutical intermediate for boronate synthesis
2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-amine
Pharmaceutical intermediate for boronate synthesis
8-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,4-dioxaspiro[4.5]decane
Pharmaceutical intermediate for boronate synthesis
2-Bromo-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 4-methylbenzenesulfonate
pharmaceutical intermediate
2-(4-Fluorophenyl)-5-methylpyridine
pharmaceutical intermediate
1-Boc-3-hydroxypiperidine
Pharmaceutical intermediate for synthesis
2-piperidin-1-yl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
MLJZIQHWAUYAPA-UHFFFAOYSA-N
B1(OC(C(O1)(C)C)(C)C)C2=CN=C(C=C2)N3CCCCC3
—